Using DNA technology and artificial intelligence to detect diseases and create targeted treatments
DNA nanotechnology and synthetic biology for AI-supported detection and precision therapeutics
This study is working on new ways to quickly and accurately find germs that make people sick and to create better treatments using cutting-edge technology, so patients can get more effective and personalized care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Albany NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project ID | NIH-11009705 on NIH RePORTER |
What this research studies
This research focuses on developing advanced methods for detecting pathogens and creating precise therapeutics using DNA nanotechnology and synthetic biology. By integrating artificial intelligence, the project aims to enhance biosensing capabilities, allowing for highly sensitive detection of various bacteria and viruses. The approach includes innovative techniques such as synthetic biology cascade reactions and CRISPR technology to identify pathogens through visual indicators. Patients may benefit from improved diagnostic tools and targeted treatments that are more effective and personalized.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with infections caused by antibiotic-resistant bacteria or those requiring precise therapeutic interventions.
Not a fit: Patients with non-infectious conditions or those not affected by antibiotic resistance may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely detection of infections, as well as tailored therapies that improve patient outcomes.
How similar studies have performed: Previous research has shown promise in using DNA nanotechnology and AI for biosensing, indicating potential for success in this innovative approach.
Where this research is happening
Albany, United States
- State University of New York at Albany — Albany, United States (Active)
Researchers
- Principal investigator: Yigit, Mehmet Veysel — State University of New York at Albany
- Study coordinator: Yigit, Mehmet Veysel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.